What NADH dose do studies and labels give?
| Product | NADH per unit | Directions |
|---|---|---|
| Nutra-Z+ (multi-ingredient label) | 5 mg per serving; the label lists a serving size of 1 tablet for a capsule product5 | 1 capsule once daily, preferably with meals or as directed by medical practitioner5 |
| NADH CONSTANT (maker's European product) | 20 mg per tablet6 | 2 tablets in the morning and 2 at lunchtime, on a pharmacy page that also lists a daily dose of 1 tablet (20 mg)6; a maker's page states a daily NADH dose of 80 mg4 |
| NADH Plus (homeopathic spray) | Nadidum 4X7 | 1 spray orally 3 times a day or as directed by a health care professional7 |
Strengths and directions on labels
The table is set at the top of the page
Searches of DailyMed, PubMed, the trial registry and RxList found no label or regulator that gives a usual NADH dose. Virexa, another multi-ingredient label that lists NADH without an amount, gives a usual adult dose of 1 tablet once or twice daily or as prescribed by a licensed medical practitioner.8
RxList, a consumer reference rather than a label, gives 10 mg as the amount each day, in a passage saying NADH seems safe for most people in the short term, up to 12 weeks.9 It also says the appropriate dose depends on several factors such as the user's age and health, and that there is not enough scientific information to determine an appropriate range of doses.9
Doses used in trials
Trials in chronic fatigue syndrome (CFS) used 10 to 20 mg of NADH, alone or with coenzyme Q10 (CoQ10).123
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Forsyth 19991 | 10 mg NADH alone or placebo, then crossed over | 26 patients | 4 weeks per period, 4-week washout |
| Alegre 20102 | 20 mg oral NADH alone or placebo | 86 enrolled, 77 completed | 3 months, treatment in the first two months |
| Castro-Marrero 20153 | 20 mg/day NADH plus 200 mg/day CoQ10 in soft gel capsules, or matching placebo | 73 women (thirty-nine active, thirty-four placebo) | 8 weeks |
| Castro-Marrero ME/CFS trial10 | 200 mg CoQ10 and 20 mg NADH or matching placebo, once daily (as the paper's summary gives it) | 207 patients (104 and 103) | 12-week trial: 8 weeks of treatment, then a visit four weeks after treatment ended |
The same paper's methods give 72 patients in each arm, given four capsules daily for eight weeks while all also received their standard therapy, so its figures differ from the summary's.10
In the jet lag trial (Birkmayer 2002), thirty-five healthy, employed people were randomised on arrival to 20 mg of sublingual stabilised NADH (n = 18) or identical placebo tablets (n = 17).11
Registry entry NCT03186027 (282 enrolled), the entry for the later Castro-Marrero ME/CFS trial, lists NADH 20 mg/day with CoQ10 200 mg/day as 4 tablets/day for 8 weeks, divided into 2 daily doses (2 tablets before breakfast and 2 before lunch), each tablet holding CoQ10 50 mg plus NADH 5 mg, against placebo on the same schedule.1210 Registry entry NCT02063126 (80 enrolled), under which the 2015 Castro-Marrero trial of 73 women was registered, lists NADH 20 mg/day plus CoQ10 200 mg/day divided into two daily doses (2 tablets before breakfast, 2 before lunch), against placebo on the same schedule.133
How NADH is taken
No label states a route for NADH alone. The 2015 CFS trial gave it by mouth in soft gel capsules, the later CFS trial paper describes four enteric-coated tablets daily in one passage and four capsules daily in another, and the jet lag trial gave sublingual stabilised NADH against identical placebo tablets.31011
Storage
The Nutra-Z+ and Virexa labels, both multi-ingredient products, give storage at 20 to 25 C with excursions permitted to 15 to 30 C, and the Virexa label adds a cool dry place.58 The DailyMed search found storage only for multi-ingredient products, and no NADH-specific stability data.
Frequently asked questions
What is the maximum NADH dose?
Searches of PubMed, DailyMed and RxList found no maximum NADH dose from a label or regulator. A 2024 systematic review of 10 randomised trials (489 participants) of NAD+ and NADH says NADH supplementation is safe and has a low incidence of side effects, notes that all studies showed some side effects, and calls for future work on the doses given.14 The later ME/CFS trial of NADH with CoQ10 (Castro-Marrero, 207 patients) reported no serious adverse events and no relevant treatment-related adverse events, while 19 participants dropped out due to adverse effects: eight in the active group (five epigastralgias and three dizziness) and 11 in the placebo group.10
Is NADH mixed from powder and drawn into a syringe?
A search of DailyMed and maker pages found no label or leaflet for mixing NADH powder, so there is no water volume or syringe mark to work out.
- NADHThe NADH compound page.
- SupplementsMore supplements in the library.
- Units and dosingHow mg, mcg and IU are read.
- Creatine monohydrateHow another oral supplement is taken.
- Cholecalciferol dosageWhat studies and labels give for vitamin D3.
- Omega-3 fish oil dosageWhat studies and labels give for fish oil.
References
- PubMed. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. 1999. pubmed.ncbi.nlm.nih.gov
- PubMed. [Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome]. 2010. pubmed.ncbi.nlm.nih.gov
- PMC. Does Oral Coenzyme Q10 Plus NADH Supplementation Improve Fatigue and Biochemical Parameters in Chronic Fatigue Syndrome?. 2015. pmc.ncbi.nlm.nih.gov
- Birkmayer (via Ingredients Network). Prof. George Birkmayer NADH CONSTANT | Prof. George Birkmayer NADH | Ingredients Network. ingredientsnetwork.com
- DailyMed. Nutra-Z+ Capsules. 2022. dailymed.nlm.nih.gov
- Birkmayer (via onlineapo.at). Prof George Birkmayer NADH CONSTANT Tablets. onlineapo.at
- DailyMed. DRUG FACTS:. 2026. dailymed.nlm.nih.gov
- DailyMed. Virexa. 2025. dailymed.nlm.nih.gov
- RxList. Nadh: Health Benefits, Side Effects, Uses, Dose & Precautions. rxlist.com
- PMC. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. 2021. pmc.ncbi.nlm.nih.gov
- PubMed. [Stabilized NADH (ENADA) improves jet lag-induced cognitive performance deficit]. 2002. pubmed.ncbi.nlm.nih.gov
- ClinicalTrials.gov. NCT03186027: Coenzyme Q10 Plus NADH Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. 2021. clinicaltrials.gov
- ClinicalTrials.gov. NCT02063126: Clinical Trial to Measure the Maximun HR After ReConnect ® Supplementation vs. Placebo in CFS. 2013. clinicaltrials.gov
- PubMed. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. 2024. pubmed.ncbi.nlm.nih.gov